LifeFlow by 410 Medical
Financial Services · Design & Creative
$51.2Mtotal raised · 16 rounds on record
$10.3Mlatest round · Venture round · Jun 2026 · 4 mo ago
$4.9Mgrants · 9 grants · CORDIS
200+team · employees, estimated range
Overview
Improve resuscitation through earlier and controlled blood and fluid delivery. Hemorrhagic shock following penetrating trauma is associated with high mortality and requires immediate resuscitation with blood products.
Funding and backers
Total raised
$51.2M
16 rounds on record
Latest round
$10.3M
Venture round · Jun 2026 · 4 mo ago
Team
201-500
employees, estimated range
Grants
$4.9M
9 grants · CORDIS
The money's age
Fresh money
4 months since the last round · not hiring
Momentum
35/100
in the news, fresh money
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jul 15
Board appointment Fred Goldwater, Director · SEC Form D
Jun 30
Raised a round Venture round $10.3M · SEC Form D
Aug 29, 2024
Won a grant $1.2M · CORDIS
Aug 19, 2024
Won a grant $1.8M · CORDIS
Dec 8, 2023
Won a grant $110k · CORDIS
Oct 31, 2022
Won a grant $75k · CORDIS
Jul 20, 2022
Won a grant $750k · CORDIS
Mar 7, 2022
Won a grant $747k · CORDIS
Nov 2, 2021
Won a grant $50k · CORDIS
Nov 1, 2021
Won a grant $50k · CORDIS
Apr 14, 2021
Won a grant $50k · CORDIS
Oct 21, 2019
Raised a round Venture round $7.6M · SEC Form D
Aug 7, 2018
Took on debt financing $3.1M · SEC Form D
Mar 17, 2017
Raised a round Venture round $5.4M · SEC Form D
Apr 12, 2016
Raised a round Venture round $2.2M · SEC Form D
2013
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jun 2026 | $10.3M | — | SEC Form D |
| Grant | Aug 2024 | $1.2M | — | CORDIS |
| Grant | Aug 2024 | $1.8M | — | CORDIS |
| Grant | Dec 2023 | $110k | — | CORDIS |
| Grant | Oct 2022 | $75k | — | CORDIS |
| Venture round | Oct 2022 | $25.7M | — | SEC Form D |
| Grant | Jul 2022 | $750k | — | CORDIS |
| Grant | Mar 2022 | $747k | — | CORDIS |
| Debt Financing | Dec 2021 | $3.1M | — | SEC Form D |
| Grant | Nov 2021 | $50k | — | CORDIS |
| Grant | Nov 2021 | $50k | — | CORDIS |
| Grant | Apr 2021 | $50k | — | CORDIS |
| Venture round | Oct 2019 | $7.6M | — | SEC Form D |
| Debt Financing | Aug 2018 | $3.1M | — | SEC Form D |
| Venture round | Mar 2017 | $5.4M | — | SEC Form D |
| Venture round | Apr 2016 | $2.2M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | 410 Medical, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Mark PiehlExecutive Officer, DirectorSEC Form D
Kyle ChenetExecutive Officer, DirectorSEC Form D
Galen RobertsonExecutive OfficerSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers

NKA Bio was founded with a mission to improve trauma care by solving shock. The company is focused on its primary product NKA01 for Trauma…

Blood analysis for the 21st Century. Supporting immediate, evidence-based decision making.

Award-winning digital therapeutic programs for diabetes care and weight loss trusted by doctors. 15K+ people have prevented, managed and…

Lower your blood sugar level & improve your health in 12 weeks.
Financials
Total raised
$62.3M
Latest round
Venture - Series Unknown
Funding rounds
16
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2026 | $10.3M | Details |
| Grant | 2024 | $1.2M | Details |
| Grant | 2024 | $1.8M | Details |
| Grant | 2023 | $110k | Details |
| Grant | 2022 | $75k | Details |
| Venture - Series Unknown | 2022 | $25.7M | Details |
| Grant | 2022 | $750k | Details |
| Grant | 2022 | $747k | Details |
| Debt Financing | 2021 | $3.1M | Details |
| Grant | 2021 | $50k | Details |
| Grant | 2021 | $50k | Details |
| Grant | 2021 | $50k | Details |
| Venture - Series Unknown | 2019 | $7.6M | Details |
| Debt Financing | 2018 | $3.1M | Details |
| Venture - Series Unknown | 2017 | $5.4M | Details |
| Venture - Series Unknown | 2016 | $2.2M | Details |
People

Mark Piehl
Executive Officer, Director

Kyle Chenet
Executive Officer, Director

Galen Robertson
Executive Officer

Lukas Roush
Director

Mike Liddell
Director

Larry Miller
Director

Travis Whitfill
Director

Dan Duffy
Director

John Tushar
Director

Daniel Duffy
Director

Stanley Lynall
Director

Jeff Terrell
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
News
First Use, Immediate Impact for a Critical Access Hospital: LifeFlow and QinFlow Warrior in a Massive Transfusion Protocol
Hemorrhagic shock following penetrating trauma is associated with high mortality and requires immediate resuscitation with blood products. Traditional rapid infusion methods used for massive transfusion protocols (MTP) are often complex and unreliable, li
Read more
Report
Septic Shock in a Pediatric Patient: Rapid Fluid Resuscitation with LifeFlow Supports Early Hemodynamic Stabilization
Case Summary A 2-year-old male was evaluated by the Community Fire Department after developing fever, lethargy, and an episode of unresponsiveness at home. EMS identified signs of poor perfusion that progressed rapidly, raising concern for decompensated s
Read more
Report
Rapid Prehospital Blood Transfusion Stabilizes Patient Following a Motor Vehicle Accident and Prolonged Extrication Ridgeview Ambulance
Case Summary Ridgeview Ambulance responded to a motor vehicle collision involving a 25-year-old female who was trapped beneath the dashboard and required a prolonged extrication. Upon EMS arrival, the crew suspected severe hemorrhagic shock from suspected
Read more
Report
GI Hemorrhage in a Cirrhotic Patient: LifeFlow Delivery Enables Rapid Resuscitation and Bridge to Interventional Radiology
Upper gastrointestinal bleeding is one of the most common life-threatening emergencies encountered in the emergency department. In the US, acute GI hemorrhage accounts for approximately 300,000 hospitalizations annually, with overall in-hospital mortality
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Durham
United States
HQ
410 Medical
200-500 est. staff
68 T.W. Alexander Drive, Durham, NC 27713




